ArticleMolecular biology reports2026
Ginseng alleviates fatigue by inhibiting autophagy via activation of the PI3K/AKT/mTOR signaling pathway.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPanax ginseng C. A. Mey. (PG) is a commonly used traditional Chinese medicine to relieve fatigue-related symptoms. However, the underlying mechanisms by which PG alleviates fatigue are still not fully understood. This study aims to elucidate the anti-fatigue mechanism of PG in a hyperammonemia induced fatigue mouse model.
methodsThe therapeutic effects of PG on hyperammonemia-induced fatigue mice were evaluated using behavioral assessments, including rotarod, open field, grip strength, and tail suspension tests, along with serum biochemical analysis and hematoxylin-eosin (HE) staining. To investigate the molecular mechanisms, an integrated approach combining transcriptomics, proteomics, network pharmacology, immunohistochemistry, immunofluorescence, and Western blot was employed.
resultsPG significantly enhanced the exercise tolerance of hyperammonemia-induced fatigue mice, ameliorated skeletal muscle fiber atrophy, and restored the serum ammonia, creatine kinase, blood urea nitrogen, lactate dehydrogenase, and blood glucose levels. Comprehensive analysis of transcriptomics, proteomics and network pharmacology indicated that the mechanism of anti-fatigue of PG may be mediated by regulating autophagy via the PI3K/AKT signaling pathway. In addition, immunohistochemistry, Western blot, and immunofluorescence analysis confirmed that PG protected against fatigue by activating the PI3K/AKT/mTOR pathway to restore dysregulated autophagy in skeletal muscle under hyperammonemia conditions.
conclusionsPG may alleviate fatigue by inhibiting excessive autophagy via the PI3K/AKT/mTOR pathway and restoring the protein balance within skeletal muscle.
Indexed as
Identifiers
42859269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.